Compare Amgen, Inc. (AMGN) vs Datadog Inc (DDOG) Price & Performance

Amgen, Inc.Trade

Datadog IncTrade

Price performance (Past 24H)

Key statistics

Amgen, Inc. vs Datadog Inc — how do they compare? Amgen, Inc. trades at $412.21 (market cap $224.14B), while Datadog Inc trades at $244.04 (market cap $88.61B). The key difference: Amgen, Inc. is far larger — about 2.5× Datadog Inc's market cap, and Amgen, Inc. pays a 2.43% dividend while Datadog Inc pays none. Which is the better fit depends on your goals.

	AMGN	DDOG
Market Cap	$224.14B	$88.61B
Sector	Health	Technology
52-Week High	$417.20	$288.15
52-Week Low	$271.18	$102.62
Enterprise Value	$267.45B	$84.90B
Dividend Yield	2.43%	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

AMGN

BioCryst hits profitability with strong Q2 revenue, sparking takeover interest in rare disease biotech.24/7 Wall Street · 1 day agoBullish View details →

DDOG

Fastly shares jump 21% on strong Q2 results and raised full-year outlook, hitting highest levels since early 2024.24/7 Wall Street · 1 day agoBullish Global X Cloud Computing ETF (CLOU) rated buy for strong growth beyond AI and resilient revenue streamsSeeking Alpha · 2 days agoBullish Software stocks swing as AI fears hit valuations; Atlassian and Twilio rally after earnings.CNBC · 4 days agoNeutral View details →

About Amgen, Inc.

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).

About Datadog Inc

Datadog is a cloud-native company that focuses on analyzing machine data. The firm's product portfolio, delivered as software-as-a-service, allows a client to monitor and analyze its entire IT infrastructure. Datadog's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to utilize it for a variety of different applications throughout their businesses.